• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8
3

COUNTRY

8

CATEGORIES

  • 9
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1

PRICE

9
10
15
22

PUBLISHED

1
3
11
22

PRODUCT TYPE

17
5

Search "China Company Research - Jiangsu Hengrui Medicine Co., Ltd " returned 22 results.

PRODUCT TITLE
Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012 Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012 - Product Thumbnail Image

Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012

" Since 2006, the proportion of China pharmaceutical industry output in GDP has remained stable In the past five years, the proportion fell slightly in 2007, while in other years it kept a growth trend...

November 2011
FROM

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

August 2014
FROM
Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010 Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010 - Product Thumbnail Image

Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010

In 2008, the sales of Chinese pharmaceutical industry amounted to RMB 677 776 billion, rising by over 20% YOY Among the sub-industries, the sales growth rate of the biological product industry was 31...

December 2009
FROM
Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011 Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011 - Product Thumbnail Image

Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011

In China, the chemical pharmaceutical industry includes the chemical API industry and the chemical preparation industry The chemical active pharmaceutical ingredients (API) manufacture refers to the...

October 2010
FROM
Research Report of Chinese Off-patent Drug Market, 2009 Research Report of Chinese Off-patent Drug Market, 2009 - Product Thumbnail Image

Research Report of Chinese Off-patent Drug Market, 2009

The off-patent drugs refer to a kind of copy drug, which have the same dosage, security, strength, quality, performance and intended uses to the commercial name drugs The legal acquirement of the off-patent...

April 2009
FROM

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations....

June 2013
FROM

Hubei Qianjiang Pharmaceutical, Ltd.

A textual analysis of the financial results for Hubei Qianjiang Pharmaceutical, Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements,...

October 2014

Chongqing Taiji Industry (Group)

A textual analysis of the financial results for Chongqing Taiji Industry (Group) compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

August 2014
Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007 Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007 - Product Thumbnail Image

Company Study of Jiangsu Hengrui Medicine Co, Ltd., 2007

Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the companys profit. In the...

June 2007
FROM
Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007 Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007 - Product Thumbnail Image

Company Study of Jiangsu Hengrui Medicine Co, Ltd. 2007

Jiangsu Hengrui Medicine Co., Ltd. mainly produces anti-tumor drugs, anti-infectious drugs, antibiotic drugs and drugs for operation, and the first kind generates most of the companys profit. In the...

June 2007
FROM

Throat Cancer Global Clinical Trials Review, H1, 2012

Throat Cancer Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Throat Cancer Global Clinical Trials Review, H1, 2012" provides data on the Throat Cancer clinical...

January 2012
FROM

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development...

January 2014
FROM

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development...

January 2014
FROM

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

March 2014
FROM
Liver Cancer - Pipeline Review, H1 2012 Liver Cancer - Pipeline Review, H1 2012 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H1 2012

Liver Cancer – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H1 2012', provides an overview of the Liver Cancer therapeutic pipeline. This report provides...

January 2012
FROM

Throat Cancer Global Clinical Trials Review, H2, 2013

Throat Cancer Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Throat Cancer Global Clinical Trials Review, H2, 2013" provides data on the Throat Cancer clinical trial scenario....

November 2013
FROM

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Chemotherapy...

June 2014
FROM

China Pharmaceutical Guide 2014 (9th Edition)

Written by veteran pharma industry executives to help guide international players navigate through thecomplex and turbulent Chinese healthcare business environment, it is the most authoritative reference...

July 2014
FROM

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011

Non-Small Cell Lung Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H2 2011', provides an overview of the Non-Small Cell Lung Cancer...

September 2011
FROM

Lung Cancer - Pipeline Review, Q3 2011

Lung Cancer - Pipeline Review, Q3 2011 Summary Global Markets Direct’s, 'Lung Cancer - Pipeline Review, Q3 2011', provides an overview of the Lung Cancer therapeutic pipeline. This report provides...

July 2011
FROM
Loading Indicator

Our Clients

Our clients' logos